Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...

“It’s genuinely surprising that the add-on gives vancomycin any ability at all to hit gram negatives,” says Kim Lewis, an ...

We studied the prevalence of recurrent vancomycin-resistant Enterococcus (VRE) bacteremia, predisposing factors, and strain relatedness during a 3 year period at our institution. Of 36 inpatients who ...

The attainment of life goals by adult survivors of childhood cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This ...

Outbreak of Vancomycin‐Resistant Enterococcus Colonization Among Pediatric Oncology Patients Sheila M. Nolan , MD, Jeffrey S. Gerber , MD, PhD, Theoklis Zaoutis , MD, MSCE, Priya Prasad , MPH, Susan ...

Antibiotic resistance is a major concern, particularly for immunocompromised patients, who are at greater risk of serious infections. Microbiota composition can help prevent pathogenic bacteria from ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

To the Editor: The report by Ostrowsky et al. (May 10 issue) 1 provides evidence that active infection-control interventions can reduce or eliminate the transmission of vancomycin-resistant ...

Theresa Wagner has studied enterococci and antibiotic resistance for several years. Here she is photographed in connection with another research project on enterococci. Creating new vaccines is one of ...

WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...